Your browser doesn't support javascript.
loading
Measuring cancer burden in prostatic needle core biopsies: simplified assessments outperform complex measurements in assessing outcome: evidence to assist pathologist efficiency and minimize datasets.
Berney, Daniel M; Finnegan, Kier; Chu, Kim; Fine, Samson W; Varma, Murali; Cuzick, Jack; Beltran, Luis.
Afiliação
  • Berney DM; Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Finnegan K; Department of Cellular Pathology, Barts Health NHS Trust, The Royal London Hospital, London, UK.
  • Chu K; Centre for Prevention, Detection and Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, UK.
  • Fine SW; Centre for Prevention, Detection and Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, UK.
  • Varma M; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Cuzick J; Department of Cellular Pathology, University Hospital of Wales, Cardiff, WLS, UK.
  • Beltran L; Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, UK.
Histopathology ; 82(7): 1021-1028, 2023 Jun.
Article em En | MEDLINE | ID: mdl-36779238
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Antígeno Prostático Específico Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Antígeno Prostático Específico Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article